Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease. 2008

Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
Department of Cardiology, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom. rschrale@hotmail.com

BACKGROUND This study evaluates the in-hospital, 30 day and long-term results of stenting for unprotected left main coronary artery disease in our institution. METHODS Between April 2001 and October 2005 all unprotected left main cases were retrospectively reviewed. Outcomes were obtained by case note review and postal questionnaire; primary care physicians were contacted to complete missing data. RESULTS We identified 100 consecutive patients who underwent unprotected left main procedures, 1.44% of the institution PCI volume. Indications for a percutaneous strategy were non-surgical candidates (47), emergency revascularisation (25) and patient/physician preference (28). Overall procedural success was 97%. The majority of cases (n=78) were performed with a single-stent strategy. 55% received a drug-eluting stent. There were 7 in-hospital deaths, 5 in the emergency group (cardiogenic shock) and 2 non-CABG candidates. Post hospital discharge long-term clinical follow-up was 651+/-431 days (range 6-1741). There were 8 deaths post discharge. Patients presenting as an emergency had a 72% survival rate at long-term follow-up, non-surgical candidates 83%, and patient/physician preference group had a 100% long-term survival. Multivariate analysis revealed cardiogenic shock (HR=7.9, 95% CI 1.7-3.6, p=0.008), failed thrombolysis (HR=8.5, 95% CI 1.7-41.7, p=0.008) and use of a bare-metal stent (HR=4.4, 1.1-17.0, p=0.034) were independent predictors of mortality. CONCLUSIONS Our data suggest that in contemporary practice stenting for unprotected left main disease can be considered as an alternative treatment to surgery for selected patients. The results of randomised controlled trials are awaited.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
February 2010, International journal of cardiology,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
March 2020, The Journal of invasive cardiology,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
December 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
April 2010, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
June 2020, International journal of cardiology,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
June 2003, Journal of interventional cardiology,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
April 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
April 2010, World journal of cardiology,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
February 2010, Cardiology clinics,
Ryan G Schrale, and W van Gaal, and K M Channon, and J C Forfar, and O J Ormerod, and A P Banning
January 2012, The Canadian journal of cardiology,
Copied contents to your clipboard!